Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: A case series

American Heart Journal

Volumn 139, Issue 1 I, 2000, Pages 114-121

  Allen LaPointe, Nancy M ^a,b   Li, Phoebe ^a,b  

^a DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^b Santa Clara Valley Health & Hospital System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; QUINIDINE GLUCONATE; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; RASH; TREATMENT INDICATION;

EID: 0033958373     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(00)90317-x     Document Type: Article

References (31)

1. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery. JAMA 1996;276:300-6.
2. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-49.
3. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996;94:390-7.
4. Lauer MS, Eagle KA, Buckley MJ, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989;31:367-78.
5. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997;336:1429-34.
6. Harpole DH, Liptay MJ, DeCamp MM, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 1996;61:977-82.
7. Frost L, Molgaard H, Christiansen EH, et al. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventative trials. Int J Cardiol 1992;36:253-61.
8. Pires, LA, Wagshal AB, Lancey R, et al. Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am Heart J 1995;129:799-808.
9. Woo E, Greenblatt DJ. A reevaluation of intravenous quinidine. Am Heart J 1978;96:829-31.
10. Hirschfeld DS, Ueda CT, Rowland M, et al. Clinical and electrophysiological effects of intravenous quinidine in man. Br Heart J 1977;39:309-16.
11. Swerdlow CD, Yu JO, Jacobson E, et al. Safety and efficacy of intravenous quinidine. Am J Med 1983;75:36-42.
12. Holzberger PT, Greenberg ML, Paicopolis MC, et al. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiology testing. Am Heart J 1998;136:49-56.
13. Conrad KA, Molk BL, Chidsey CA. Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation 1977;55:1-7.
14. Greenblatt DJ, Pfeiffer HJ, Ochs HR, et al. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. J Pharmacol Exp Ther 1977;202:365-78.
15. Ochs HR, Grube E, Greenblatt DJ, et al. Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans. Am Heart J 1980;99:468-75.
16. Bhavnani S, Preston SL. Monitoring of intravenous quinidine infusion in the treatment of plasmodium falciparum malaria. Ann Pharmacol 1995;29:33-5.
17. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med 1989;321:65-70.
18. Phillips RE, Warrell DA, White NJ, et al. Intravenous quinidine for the treatment of severe falciparum malaria. N Engl J Med 1985;312:1273-8.
19. Treatment with quinidine gluconate of persons with severe plasmodium falciparum infection: discontinuation of parenteral quininin form CDC Drug Service. Morb Mortal Wkly Rep 1991;40:21-3.
20. Intravenous quinidine gluconate in the treatment of severe plasmodium falciparum infections. Morb Mortal Wkly Rep 1985;34:371.
21. Agosti JM, Miller KD, Pappaioanou M, et al. Plasmodium falciparum malaria and intravenous quinidine gluconate. Ann Intern Med 1985;103:307.
22. White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6.
23. White NJ, Looareesuwan S, Warrell DA, et al. Quinidine in falciparum malaria. Lancet. 1981;2:1069-71.
24. Trissel LA. Handbook of injectable drugs. 9th edition. Bethesda, Md: American Society of Health System Pharmacists; 1996. p. 957-8.
25. Gold MR, O'Gara PT, Buckley MJ, et al. Efficacy and safety of procainamide in preventing arrhythmias after coronary bypass surgery. Am J Cardiol 1996;78:975-9.
26. Laub GW, Janeira L, Muralidharan S, et al. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: a prospective, double-blind, randomized, placebo-controlled pilot study. Crit Care Med 1993;21:1474-8.
27. Mattioni T, Denker S, Riggio D, et al. Efficacy and safety of intravenous ibutilide in the treatment of atrial flutter and atrial fibrillation following valvular or coronary artery bypass surgery [abstract]. PACE 1997;20:1059.
28. McAlister HF, Luke RA, Whitlock RM, et al. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. J Thorac Cardiovasc Surg 1990;99:911-8.
29. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-91.
30. Guarnieri T. Post CABG IV amiodarone decreases incidence of atrial fibrillation: results from ARCH. Presented at the ACC meeting. Atlanta, Ga: 1998.
31. Desai AD, Chun S, Sung RJ. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med 1997;127:294-303.